Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Virology Vol. 80; no. 6; pp. 2654 - 2664
Main Authors: EREN, Rachel, LANDSTEIN, Dorit, AVIEL, Sigal, ILAN, Ehud, SHOSHANY, Yariv, NEVILLE, Lewis, WAISMAN, Tal, BEN-MOSHE, Ofer, KISCHITSKY, Alberto, FOUNG, Steven K. H, KECK, Zhen-Yong, PAPPO, Orit, TERKIELTAUB, Dov, EID, Ahmed, JURIM, Oded, ZAMIR, Gidi, GALUN, Eithan, DAGAN, Shiomo, NUSSBAUM, Ofer, ZAUBERMAN, Arie, BEN-PORATH, Judith, GOPHER, Judith, BUCHNICK, Rachel, KOVJAZIN, Riva, ROSENTHAL-GALILI, Ziva
Format: Journal Article
Language:English
Published: Washington, DC American Society for Microbiology 01-03-2006
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Corresponding author. Mailing address: XTL Biopharmaceuticals Ltd., Rehovot, Israel. Phone: 972-89304443. Fax: 972-89304445. E-mail: sdagan@xtlbio.com.
ISSN:0022-538X
1098-5514
DOI:10.1128/JVI.80.6.2654-2664.2006